Comparing simple meal boluses to carbohydrate counting for blood sugar control in adolescents with type 1 diabetes
Official title: Using Simplified Meal Boluses Versus Carbohydrate Counting in Adolescents With Hybrid Closed Loop Systems: A Randomized Crossover Trial
Run by University of Colorado, Denver · NCT06575790 · Data updated 2026-11-12
This study tests whether a simpler way of calculating insulin doses for meals can help teenagers with type 1 diabetes manage their blood sugar better than the traditional method of counting carbohydrates.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 26 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Colorado, Denver Academic / other |
| Locations | 1 site (Aurora, Colorado) |
| Status | Recruiting |
| Started | November 25, 2024 |
| Main results expected | September 30, 2025 |
| Study ends | September 30, 2025 |
| Registry record updated | December 10, 2024 |
| Trial ID | NCT06575790 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents and adults diagnosed with type 1 diabetes for at least one year who are using a commercial hybrid closed loop system.
✕Probably not a fit
Patients with a history of severe hypoglycemic events or other significant health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates blood sugar control in adolescents and adults with type 1 diabetes using a simplified meal bolus strategy versus traditional carbohydrate counting while on hybrid closed loop systems. Participants will follow a simple meal bolus plan for four weeks and then switch to precise carbohydrate counting for another four weeks. The study aims to assess glycemic control, feasibility, and the impact on the burden of diabetes management. By simplifying meal bolusing, the study seeks to make diabetes management more accessible for individuals with low numeracy skills.
Why it matters
Potential benefit: If successful, this approach could simplify diabetes management and improve blood sugar control for patients using hybrid closed loop systems.
How similar studies have gone: While the approach of simplifying meal bolusing is innovative, similar studies have shown that hybrid closed loop systems can improve glycemic control, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Clinical diagnosis of T1D of at least 1 year duration * Using a commercial HCL system * Willingness to not start any new non-insulin glucose-lowering agent during trial * Willingness to participate in all study procedures * Investigator has confidence that participant can successfully operate all study devices and adhere to protocol Exclusion Criteria: * History of \>1 severe hypoglycemic event with seizure or loss of consciousness in the last 6 months or \>1 DKA event in the last 6 months not related to illness or infusion set failure * History of chronic renal disease or currently on hemodialysis, adrenal insufficiency, hypothyroidism that is not adequately treated, use of oral or injectable steroids within the last 8 weeks, or known ongoing adhesive intolerance * A condition, which in the opinion of the investigator or designee, would put the participant or study at risk * Participation in another interventional trial at the time of enrollment * Pregnancy
Where it's running
-
Barbara Davis Center
Aurora, Colorado, United States Recruiting
Study contacts
- Study coordinator: Alexandra Sawyer, MD, MPH
- Email: alexandra.sawyer@childrenscolorado.org
- Phone: 303-724-2323
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Semaglutide on body composition in adults with type 1 diabetes and overweight/obesity
This study tests whether weekly semaglutide changes body composition in adults with type 1 diabetes who are overweight or obese, compared with a placebo over 24 weeks.
-
Next Generation Extended Wear Sensors in Type 1 and Type 2 Diabetes
This study tests a new extended wear sensor and algorithm in people with type 1 or type 2 diabetes to see how well it works across adults and children.
-
CGM-guided carb awareness education for adults with Type 1 diabetes
This study tests whether teaching mealtime insulin dosing using CGM data helps adults with Type 1 diabetes who don’t usually count carbs.
-
Safety and effectiveness of GLP-1 receptor agonists and SGLT inhibitors added to insulin in adults with type 1 diabetes
This registry will see if adding GLP-1RA or SGLTi therapies to insulin helps adults with type 1 diabetes over one year.
-
Think-Find-Solve activities for insulin self-management in children with type 1 diabetes
A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.
-
Near-sensor insulin delivery with CGM in people with type 1 diabetes
A small early-feasibility study tests a dual-port insulin patch pump that includes a CGM sensor to see if delivering insulin near the sensor affects glucose readings and whether an automated control algorithm can manage glucose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.